Aurobindo Pharma to Spin-Off Injectable Business

Published: Aug 12, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The board has considered the option of spin-off of the injectable business to a wholly owned subsidiary as a going concern, in order to strengthen and provide focused growth to the injectable business and to leverage strategic opportunities.

Help employers find you! Check out all the jobs and post your resume.

Back to news